Expression-enhanced polypeptides

Details for Australian Patent Application No. 2005263555 (hide)

Owner Micromet AG

Inventors Hoffmann, Patrick; Hennecke, Jens; Mittelstrass, Silke; Raum, Tobias

Agent Callinan

Pub. Number AU-B-2005263555

PCT Pub. Number WO2006/008096

Priority 04016890.8 16.07.04 EP

Filing date 15 July 2005

Wipo publication date 26 January 2006

Acceptance publication date 27 January 2011

International Classifications

C07K 16/00 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

C07K 16/46 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - Hybrid immunoglobulins

C12N 15/67 (2006.01) Mutation or genetic engineering - General methods for enhancing the expression

Event Publications

8 February 2007 PCT application entered the National Phase

  PCT publication WO2006/008096 Priority application(s): WO2006/008096

27 January 2011 Application Accepted

  Published as AU-B-2005263555

26 May 2011 Standard Patent Sealed

20 September 2012 Application for Amendment

  The nature of the amendment is: Amend the Patentee to read Amgen Research (Munich) GmbH . Address for service in Australia - Callinans 1193 Toorak Road Camberwell VIC 3124

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005263566-Selective insecticides and/or acaricides based on substituted, cyclic dicarbonyl compounds and safeners

2005263551-Use of a steroid for enhancement of skin permeability